KIMBERLY FANGUY: Open Payments
NPI 1750828398 · WEST COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,157 in 85 payments from 23 companies in 2025. Trend: 2023 $100 · 2024 $1,789 · 2025 $2,157
Food & beverage: $2,045Education: $111
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $461 |
| AstraZeneca Pharmaceuticals LP | 4 | $163 |
| TG Therapeutics, Inc. | 5 | $140 |
| EMD Serono, Inc. | 4 | $133 |
| Lundbeck LLC | 5 | $130 |
| Teva Pharmaceuticals USA, Inc. | 2 | $126 |
| PFIZER INC. | 6 | $112 |
| UCB, Inc. | 4 | $109 |
| Novartis Pharmaceuticals Corporation | 3 | $88 |
| Alexion Pharmaceuticals, Inc. | 3 | $87 |
Products named: QULIPTA, UBRELVY, WAINUA, BRIUMVI, Leqembi, VYEPTI, NURTEC ODT, KESIMPTA.
Industry payments across SC — which companies pay providers there.
